Menstrual irregularities
Conditions
Interventions
Wearing violet light irradiation glasses
Sponsors
Suzuki Ayako
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: Subjects who meet all of the following conditions will be included in this study: 1)Subjects who are aged 20 over and 40 under years old at the time of obtaining consent. 2)Subjects who have menstrual irregularities prior to obtaining consent* *Subjects whose menstrual cycle does not fall into the normal cycle (25~38 days) 3)Subjects who have had menstrual irregularities in the last 3 months from the interview or the patient's record 4)Subjects who are able to spend time with the naked eye or contact lenses that meet certain conditions** while wearing the research equipment. ** VL transmissive contact lenses can be used, but UV-protected contacts Lenses and colored contact lenses are not allowed. 5)Subjects who have voluntarily given written consent to participate in this study 6)Subjects who have been fully briefed on the matters to be complied with in this clinical trial, are willing to comply with the contents, and are able to comply with them.
Exclusion criteria
Exclusion criteria: Subjects who fall under any of the following will be excluded from the study: 1)Subjects with a positive pregnancy test at screening 2)Subjects with abnormalities in the retina confirmed by ophthalmologic examination at screening 3)Subjects with a history of ophthalmic surgery within 6 months prior to obtaining consent 4)Subjects with organic diseases such as pituitary amenorrhea, ovarian amenorrhea, thyroid dysfunction, and hyperprolactinemia. 5)Subjects who have undergone or are undergoing treatment for ovulation induction and hormone therapy However, among subjects who have undergone ovulation induction or hormone therapy, if they have not been treated for more than 2 months before obtaining consent and are considered to be unaffected by drugs, etc., they may be registered at the discretion of the principal investigator. 6)Subjects taking oral contraceptives 7)Pregnant or lactating Subjects 8)Subjects who have been diagnosed with neurogenic eating disorders (anorexia nervosa and bulimia nervosa) 9)Subjects who abuse or become dependent on drugs 10)Subjects who abuse or depend on alcohol 11)Subjects with serious heart disease, liver disease, renal disease, respiratory failure 12)Subjects with a history of seizures or epilepsy 13)Subjects with malignant tumors or a history within 5 years prior to obtaining consent 14)Immunocompromised Subjects or Subjects with a history of HIV infection 15)Other Subjects who are judged to be inappropriate by the principal investigator , etc., such as those who are judged by the doctor to have a history of treatment or a disease that may affect the menstrual cycle.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Changes in the menstrual cycle (the number of days from the start date of menstruation to the day before the start of the next menstrual period) over time | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.Evaluation of subjective symptoms (NRS) at each time point 2.Evaluation of each time point of the questionnaire | — |
Contacts
Public ContactAyako Suzuki
Medical Corporation Association Yukari-kai Toranomon Women's Clinic
Outcome results
None listed